nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.087	0.127	CbGbCtD
Bumetanide—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.0855	0.125	CbGbCtD
Bumetanide—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0815	0.119	CbGbCtD
Bumetanide—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0678	0.0992	CbGbCtD
Bumetanide—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0659	0.0964	CbGbCtD
Bumetanide—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0659	0.0963	CbGbCtD
Bumetanide—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0596	0.0871	CbGbCtD
Bumetanide—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0596	0.0871	CbGbCtD
Bumetanide—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0497	0.0727	CbGbCtD
Bumetanide—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0346	0.0507	CbGbCtD
Bumetanide—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0268	0.0392	CbGbCtD
Bumetanide—CFTR—semen—acquired immunodeficiency syndrome	0.00974	0.105	CbGeAlD
Bumetanide—SLC12A5—nerve—acquired immunodeficiency syndrome	0.0072	0.0776	CbGeAlD
Bumetanide—SLC12A5—retina—acquired immunodeficiency syndrome	0.00298	0.0321	CbGeAlD
Bumetanide—SLC12A1—blood plasma—acquired immunodeficiency syndrome	0.00261	0.0282	CbGeAlD
Bumetanide—SLC12A4—retina—acquired immunodeficiency syndrome	0.00248	0.0267	CbGeAlD
Bumetanide—SLC12A5—spinal cord—acquired immunodeficiency syndrome	0.00192	0.0207	CbGeAlD
Bumetanide—CA4—nerve—acquired immunodeficiency syndrome	0.00186	0.0201	CbGeAlD
Bumetanide—SLC12A5—nervous system—acquired immunodeficiency syndrome	0.00162	0.0175	CbGeAlD
Bumetanide—SLC12A4—spinal cord—acquired immunodeficiency syndrome	0.0016	0.0172	CbGeAlD
Bumetanide—SLC12A5—central nervous system—acquired immunodeficiency syndrome	0.00156	0.0168	CbGeAlD
Bumetanide—SLC12A4—lung—acquired immunodeficiency syndrome	0.00145	0.0157	CbGeAlD
Bumetanide—CFTR—digestive system—acquired immunodeficiency syndrome	0.00137	0.0147	CbGeAlD
Bumetanide—CA7—digestive system—acquired immunodeficiency syndrome	0.00134	0.0145	CbGeAlD
Bumetanide—SLC12A4—nervous system—acquired immunodeficiency syndrome	0.00134	0.0145	CbGeAlD
Bumetanide—CFTR—blood—acquired immunodeficiency syndrome	0.0013	0.014	CbGeAlD
Bumetanide—SLC12A4—central nervous system—acquired immunodeficiency syndrome	0.00129	0.014	CbGeAlD
Bumetanide—SLC12A5—brain—acquired immunodeficiency syndrome	0.00124	0.0133	CbGeAlD
Bumetanide—SLC12A2—digestive system—acquired immunodeficiency syndrome	0.0012	0.0129	CbGeAlD
Bumetanide—CA9—digestive system—acquired immunodeficiency syndrome	0.00118	0.0127	CbGeAlD
Bumetanide—SLC12A2—blood—acquired immunodeficiency syndrome	0.00114	0.0123	CbGeAlD
Bumetanide—CFTR—lung—acquired immunodeficiency syndrome	0.00114	0.0123	CbGeAlD
Bumetanide—SLC10A1—digestive system—acquired immunodeficiency syndrome	0.00113	0.0122	CbGeAlD
Bumetanide—SLC12A2—bone marrow—acquired immunodeficiency syndrome	0.00111	0.0119	CbGeAlD
Bumetanide—SLC12A2—spinal cord—acquired immunodeficiency syndrome	0.0011	0.0119	CbGeAlD
Bumetanide—SLC12A2—vagina—acquired immunodeficiency syndrome	0.00106	0.0114	CbGeAlD
Bumetanide—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.00103	0.0112	CbGeAlD
Bumetanide—CA14—spinal cord—acquired immunodeficiency syndrome	0.00103	0.0111	CbGeAlD
Bumetanide—SLC12A4—brain—acquired immunodeficiency syndrome	0.00103	0.0111	CbGeAlD
Bumetanide—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.00101	0.0109	CbGeAlD
Bumetanide—SLC12A2—lung—acquired immunodeficiency syndrome	0.001	0.0108	CbGeAlD
Bumetanide—SLC12A4—lymph node—acquired immunodeficiency syndrome	0.000993	0.0107	CbGeAlD
Bumetanide—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00097	0.0105	CbGeAlD
Bumetanide—SLC12A1—blood—acquired immunodeficiency syndrome	0.000958	0.0103	CbGeAlD
Bumetanide—SLC12A2—nervous system—acquired immunodeficiency syndrome	0.000928	0.01	CbGeAlD
Bumetanide—SLC12A1—spinal cord—acquired immunodeficiency syndrome	0.000923	0.00995	CbGeAlD
Bumetanide—Furosemide—ALB—acquired immunodeficiency syndrome	0.000913	0.582	CrCbGaD
Bumetanide—SLC12A2—central nervous system—acquired immunodeficiency syndrome	0.000893	0.00963	CbGeAlD
Bumetanide—SLC10A1—nervous system—acquired immunodeficiency syndrome	0.000876	0.00945	CbGeAlD
Bumetanide—CA12—digestive system—acquired immunodeficiency syndrome	0.000874	0.00942	CbGeAlD
Bumetanide—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000861	0.00928	CbGeAlD
Bumetanide—SLC10A1—central nervous system—acquired immunodeficiency syndrome	0.000844	0.0091	CbGeAlD
Bumetanide—CFTR—brain—acquired immunodeficiency syndrome	0.000807	0.0087	CbGeAlD
Bumetanide—CA7—brain—acquired immunodeficiency syndrome	0.000795	0.00857	CbGeAlD
Bumetanide—SLC12A1—nervous system—acquired immunodeficiency syndrome	0.000778	0.00838	CbGeAlD
Bumetanide—SLC12A1—central nervous system—acquired immunodeficiency syndrome	0.000749	0.00807	CbGeAlD
Bumetanide—CA5B—blood—acquired immunodeficiency syndrome	0.000747	0.00805	CbGeAlD
Bumetanide—CA12—lung—acquired immunodeficiency syndrome	0.00073	0.00787	CbGeAlD
Bumetanide—SLC12A2—brain—acquired immunodeficiency syndrome	0.000709	0.00764	CbGeAlD
Bumetanide—CA5B—vagina—acquired immunodeficiency syndrome	0.000692	0.00746	CbGeAlD
Bumetanide—SLC12A2—lymph node—acquired immunodeficiency syndrome	0.000685	0.00739	CbGeAlD
Bumetanide—CA12—nervous system—acquired immunodeficiency syndrome	0.000676	0.00728	CbGeAlD
Bumetanide—SLC10A1—brain—acquired immunodeficiency syndrome	0.00067	0.00722	CbGeAlD
Bumetanide—CA14—brain—acquired immunodeficiency syndrome	0.000662	0.00714	CbGeAlD
Bumetanide—Fenoprofen—ALB—acquired immunodeficiency syndrome	0.000656	0.418	CrCbGaD
Bumetanide—CA5B—lung—acquired immunodeficiency syndrome	0.000654	0.00706	CbGeAlD
Bumetanide—CA12—central nervous system—acquired immunodeficiency syndrome	0.00065	0.00701	CbGeAlD
Bumetanide—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000611	0.00659	CbGeAlD
Bumetanide—CA5B—nervous system—acquired immunodeficiency syndrome	0.000606	0.00653	CbGeAlD
Bumetanide—SLC22A7—brain—acquired immunodeficiency syndrome	0.000597	0.00644	CbGeAlD
Bumetanide—SLC12A1—brain—acquired immunodeficiency syndrome	0.000594	0.00641	CbGeAlD
Bumetanide—CA5B—central nervous system—acquired immunodeficiency syndrome	0.000583	0.00629	CbGeAlD
Bumetanide—SLC22A6—brain—acquired immunodeficiency syndrome	0.000576	0.00621	CbGeAlD
Bumetanide—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000561	0.00605	CbGeAlD
Bumetanide—SLC22A8—blood—acquired immunodeficiency syndrome	0.000556	0.006	CbGeAlD
Bumetanide—CA4—digestive system—acquired immunodeficiency syndrome	0.000541	0.00583	CbGeAlD
Bumetanide—CA12—brain—acquired immunodeficiency syndrome	0.000516	0.00557	CbGeAlD
Bumetanide—CA4—blood—acquired immunodeficiency syndrome	0.000515	0.00556	CbGeAlD
Bumetanide—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000511	0.00551	CbGeAlD
Bumetanide—CA4—bone marrow—acquired immunodeficiency syndrome	0.000499	0.00538	CbGeAlD
Bumetanide—CA4—spinal cord—acquired immunodeficiency syndrome	0.000496	0.00535	CbGeAlD
Bumetanide—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.000474	0.00214	CcSEcCtD
Bumetanide—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000473	0.0051	CbGeAlD
Bumetanide—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.000472	0.00213	CcSEcCtD
Bumetanide—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000471	0.00212	CcSEcCtD
Bumetanide—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.000471	0.00212	CcSEcCtD
Bumetanide—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.000468	0.00211	CcSEcCtD
Bumetanide—Hyperglycaemia—Ritonavir—acquired immunodeficiency syndrome	0.000467	0.0021	CcSEcCtD
Bumetanide—Pancreatitis—Lamivudine—acquired immunodeficiency syndrome	0.000466	0.0021	CcSEcCtD
Bumetanide—CA5B—brain—acquired immunodeficiency syndrome	0.000463	0.00499	CbGeAlD
Bumetanide—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.000456	0.00205	CcSEcCtD
Bumetanide—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000456	0.00205	CcSEcCtD
Bumetanide—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000455	0.00491	CbGeAlD
Bumetanide—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000454	0.00205	CcSEcCtD
Bumetanide—Renal failure—Ritonavir—acquired immunodeficiency syndrome	0.000454	0.00204	CcSEcCtD
Bumetanide—CA4—lung—acquired immunodeficiency syndrome	0.000452	0.00487	CbGeAlD
Bumetanide—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000451	0.00487	CbGeAlD
Bumetanide—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00045	0.00203	CcSEcCtD
Bumetanide—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000449	0.00202	CcSEcCtD
Bumetanide—CA5B—lymph node—acquired immunodeficiency syndrome	0.000448	0.00483	CbGeAlD
Bumetanide—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.000448	0.00202	CcSEcCtD
Bumetanide—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.000446	0.00201	CcSEcCtD
Bumetanide—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.000444	0.002	CcSEcCtD
Bumetanide—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000443	0.00199	CcSEcCtD
Bumetanide—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.000442	0.00199	CcSEcCtD
Bumetanide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000442	0.00199	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.00044	0.00198	CcSEcCtD
Bumetanide—Renal failure—Saquinavir—acquired immunodeficiency syndrome	0.000437	0.00197	CcSEcCtD
Bumetanide—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000435	0.00196	CcSEcCtD
Bumetanide—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000435	0.00469	CbGeAlD
Bumetanide—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000429	0.00193	CcSEcCtD
Bumetanide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000428	0.00193	CcSEcCtD
Bumetanide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000426	0.00192	CcSEcCtD
Bumetanide—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000424	0.00191	CcSEcCtD
Bumetanide—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000422	0.0019	CcSEcCtD
Bumetanide—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000421	0.0019	CcSEcCtD
Bumetanide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Bumetanide—CA4—nervous system—acquired immunodeficiency syndrome	0.000418	0.00451	CbGeAlD
Bumetanide—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000417	0.00188	CcSEcCtD
Bumetanide—Renal failure—Lamivudine—acquired immunodeficiency syndrome	0.000416	0.00188	CcSEcCtD
Bumetanide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000415	0.00187	CcSEcCtD
Bumetanide—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000415	0.00187	CcSEcCtD
Bumetanide—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000414	0.00446	CbGeAlD
Bumetanide—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00041	0.00185	CcSEcCtD
Bumetanide—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000406	0.00183	CcSEcCtD
Bumetanide—CA4—central nervous system—acquired immunodeficiency syndrome	0.000403	0.00434	CbGeAlD
Bumetanide—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000401	0.00181	CcSEcCtD
Bumetanide—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000397	0.00179	CcSEcCtD
Bumetanide—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000395	0.00178	CcSEcCtD
Bumetanide—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000395	0.00178	CcSEcCtD
Bumetanide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000395	0.00178	CcSEcCtD
Bumetanide—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.00176	CcSEcCtD
Bumetanide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000389	0.00175	CcSEcCtD
Bumetanide—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000389	0.00175	CcSEcCtD
Bumetanide—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000388	0.00175	CcSEcCtD
Bumetanide—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.0017	CcSEcCtD
Bumetanide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000376	0.0017	CcSEcCtD
Bumetanide—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000375	0.00169	CcSEcCtD
Bumetanide—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000375	0.00169	CcSEcCtD
Bumetanide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000371	0.00167	CcSEcCtD
Bumetanide—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00037	0.00167	CcSEcCtD
Bumetanide—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00166	CcSEcCtD
Bumetanide—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000367	0.00165	CcSEcCtD
Bumetanide—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000367	0.00165	CcSEcCtD
Bumetanide—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000366	0.00165	CcSEcCtD
Bumetanide—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000366	0.00165	CcSEcCtD
Bumetanide—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000361	0.0039	CbGeAlD
Bumetanide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00036	0.00162	CcSEcCtD
Bumetanide—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.00162	CcSEcCtD
Bumetanide—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000359	0.00162	CcSEcCtD
Bumetanide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000358	0.00161	CcSEcCtD
Bumetanide—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000357	0.00161	CcSEcCtD
Bumetanide—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000357	0.00161	CcSEcCtD
Bumetanide—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000356	0.0016	CcSEcCtD
Bumetanide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000355	0.0016	CcSEcCtD
Bumetanide—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00158	CcSEcCtD
Bumetanide—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00035	0.00158	CcSEcCtD
Bumetanide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00035	0.00158	CcSEcCtD
Bumetanide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000349	0.00157	CcSEcCtD
Bumetanide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000347	0.00156	CcSEcCtD
Bumetanide—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000347	0.00156	CcSEcCtD
Bumetanide—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000347	0.00156	CcSEcCtD
Bumetanide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000347	0.00156	CcSEcCtD
Bumetanide—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000347	0.00156	CcSEcCtD
Bumetanide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000347	0.00156	CcSEcCtD
Bumetanide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000346	0.00156	CcSEcCtD
Bumetanide—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.00156	CcSEcCtD
Bumetanide—SLC22A8—brain—acquired immunodeficiency syndrome	0.000345	0.00372	CbGeAlD
Bumetanide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000345	0.00155	CcSEcCtD
Bumetanide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000345	0.00155	CcSEcCtD
Bumetanide—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000344	0.00155	CcSEcCtD
Bumetanide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000343	0.00155	CcSEcCtD
Bumetanide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000341	0.00154	CcSEcCtD
Bumetanide—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00034	0.00153	CcSEcCtD
Bumetanide—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000339	0.00153	CcSEcCtD
Bumetanide—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000339	0.00153	CcSEcCtD
Bumetanide—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000335	0.00361	CbGeAlD
Bumetanide—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000334	0.0015	CcSEcCtD
Bumetanide—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000332	0.0015	CcSEcCtD
Bumetanide—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000332	0.0015	CcSEcCtD
Bumetanide—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000331	0.00357	CbGeAlD
Bumetanide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000327	0.00147	CcSEcCtD
Bumetanide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000326	0.00147	CcSEcCtD
Bumetanide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00147	CcSEcCtD
Bumetanide—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000325	0.00146	CcSEcCtD
Bumetanide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000324	0.00146	CcSEcCtD
Bumetanide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00146	CcSEcCtD
Bumetanide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000323	0.00145	CcSEcCtD
Bumetanide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.00145	CcSEcCtD
Bumetanide—CA4—brain—acquired immunodeficiency syndrome	0.00032	0.00345	CbGeAlD
Bumetanide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000319	0.00144	CcSEcCtD
Bumetanide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000319	0.00144	CcSEcCtD
Bumetanide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000318	0.00143	CcSEcCtD
Bumetanide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000316	0.00143	CcSEcCtD
Bumetanide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000316	0.00142	CcSEcCtD
Bumetanide—PTGS2—blood—acquired immunodeficiency syndrome	0.000315	0.0034	CbGeAlD
Bumetanide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000314	0.00142	CcSEcCtD
Bumetanide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000313	0.00141	CcSEcCtD
Bumetanide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000312	0.00141	CcSEcCtD
Bumetanide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.0014	CcSEcCtD
Bumetanide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.0014	CcSEcCtD
Bumetanide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000311	0.0014	CcSEcCtD
Bumetanide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00139	CcSEcCtD
Bumetanide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000309	0.00139	CcSEcCtD
Bumetanide—CA4—lymph node—acquired immunodeficiency syndrome	0.000309	0.00333	CbGeAlD
Bumetanide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000309	0.00139	CcSEcCtD
Bumetanide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000308	0.00139	CcSEcCtD
Bumetanide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000308	0.00139	CcSEcCtD
Bumetanide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.00139	CcSEcCtD
Bumetanide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00138	CcSEcCtD
Bumetanide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00138	CcSEcCtD
Bumetanide—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000305	0.00329	CbGeAlD
Bumetanide—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000304	0.00328	CbGeAlD
Bumetanide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000304	0.00137	CcSEcCtD
Bumetanide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000303	0.00137	CcSEcCtD
Bumetanide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000301	0.00135	CcSEcCtD
Bumetanide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.00135	CcSEcCtD
Bumetanide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.00135	CcSEcCtD
Bumetanide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000299	0.00135	CcSEcCtD
Bumetanide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000298	0.00134	CcSEcCtD
Bumetanide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000298	0.00134	CcSEcCtD
Bumetanide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.00134	CcSEcCtD
Bumetanide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000297	0.00134	CcSEcCtD
Bumetanide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00134	CcSEcCtD
Bumetanide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00133	CcSEcCtD
Bumetanide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00133	CcSEcCtD
Bumetanide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000294	0.00132	CcSEcCtD
Bumetanide—PTGS2—vagina—acquired immunodeficiency syndrome	0.000292	0.00315	CbGeAlD
Bumetanide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.0013	CcSEcCtD
Bumetanide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000289	0.0013	CcSEcCtD
Bumetanide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.0013	CcSEcCtD
Bumetanide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000288	0.0013	CcSEcCtD
Bumetanide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000288	0.0013	CcSEcCtD
Bumetanide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000287	0.00129	CcSEcCtD
Bumetanide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.00129	CcSEcCtD
Bumetanide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00128	CcSEcCtD
Bumetanide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000284	0.00128	CcSEcCtD
Bumetanide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000284	0.00128	CcSEcCtD
Bumetanide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000284	0.00128	CcSEcCtD
Bumetanide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000283	0.00127	CcSEcCtD
Bumetanide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00127	CcSEcCtD
Bumetanide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00127	CcSEcCtD
Bumetanide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00028	0.00126	CcSEcCtD
Bumetanide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000278	0.00125	CcSEcCtD
Bumetanide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000278	0.00125	CcSEcCtD
Bumetanide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.00125	CcSEcCtD
Bumetanide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000277	0.00125	CcSEcCtD
Bumetanide—PTGS2—lung—acquired immunodeficiency syndrome	0.000277	0.00298	CbGeAlD
Bumetanide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00124	CcSEcCtD
Bumetanide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000275	0.00124	CcSEcCtD
Bumetanide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000275	0.00124	CcSEcCtD
Bumetanide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.00124	CcSEcCtD
Bumetanide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000275	0.00124	CcSEcCtD
Bumetanide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.00124	CcSEcCtD
Bumetanide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000274	0.00124	CcSEcCtD
Bumetanide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.00123	CcSEcCtD
Bumetanide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000274	0.00123	CcSEcCtD
Bumetanide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000273	0.00123	CcSEcCtD
Bumetanide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000273	0.00123	CcSEcCtD
Bumetanide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Bumetanide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00122	CcSEcCtD
Bumetanide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000271	0.00122	CcSEcCtD
Bumetanide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00027	0.00122	CcSEcCtD
Bumetanide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000269	0.00121	CcSEcCtD
Bumetanide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000268	0.00121	CcSEcCtD
Bumetanide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.00121	CcSEcCtD
Bumetanide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00119	CcSEcCtD
Bumetanide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00119	CcSEcCtD
Bumetanide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00119	CcSEcCtD
Bumetanide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.00118	CcSEcCtD
Bumetanide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.00118	CcSEcCtD
Bumetanide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00117	CcSEcCtD
Bumetanide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00117	CcSEcCtD
Bumetanide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000259	0.00117	CcSEcCtD
Bumetanide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000259	0.00117	CcSEcCtD
Bumetanide—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000256	0.00276	CbGeAlD
Bumetanide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000255	0.00115	CcSEcCtD
Bumetanide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00114	CcSEcCtD
Bumetanide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.00114	CcSEcCtD
Bumetanide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00114	CcSEcCtD
Bumetanide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Bumetanide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.00113	CcSEcCtD
Bumetanide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00025	0.00113	CcSEcCtD
Bumetanide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000249	0.00112	CcSEcCtD
Bumetanide—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000247	0.00266	CbGeAlD
Bumetanide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.0011	CcSEcCtD
Bumetanide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Bumetanide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.00108	CcSEcCtD
Bumetanide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00108	CcSEcCtD
Bumetanide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000239	0.00108	CcSEcCtD
Bumetanide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00108	CcSEcCtD
Bumetanide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.00107	CcSEcCtD
Bumetanide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000237	0.00107	CcSEcCtD
Bumetanide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.00106	CcSEcCtD
Bumetanide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00105	CcSEcCtD
Bumetanide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.00105	CcSEcCtD
Bumetanide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00105	CcSEcCtD
Bumetanide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00105	CcSEcCtD
Bumetanide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00104	CcSEcCtD
Bumetanide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00103	CcSEcCtD
Bumetanide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.00103	CcSEcCtD
Bumetanide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.00101	CcSEcCtD
Bumetanide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00101	CcSEcCtD
Bumetanide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.00101	CcSEcCtD
Bumetanide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00101	CcSEcCtD
Bumetanide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000224	0.00101	CcSEcCtD
Bumetanide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000222	0.001	CcSEcCtD
Bumetanide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000222	0.000999	CcSEcCtD
Bumetanide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000996	CcSEcCtD
Bumetanide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000221	0.000994	CcSEcCtD
Bumetanide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.000991	CcSEcCtD
Bumetanide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000981	CcSEcCtD
Bumetanide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000967	CcSEcCtD
Bumetanide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000962	CcSEcCtD
Bumetanide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.000953	CcSEcCtD
Bumetanide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.000951	CcSEcCtD
Bumetanide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000948	CcSEcCtD
Bumetanide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000945	CcSEcCtD
Bumetanide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000944	CcSEcCtD
Bumetanide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000209	0.000942	CcSEcCtD
Bumetanide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000939	CcSEcCtD
Bumetanide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000938	CcSEcCtD
Bumetanide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000916	CcSEcCtD
Bumetanide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000912	CcSEcCtD
Bumetanide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000907	CcSEcCtD
Bumetanide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000904	CcSEcCtD
Bumetanide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000903	CcSEcCtD
Bumetanide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000903	CcSEcCtD
Bumetanide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000898	CcSEcCtD
Bumetanide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.00089	CcSEcCtD
Bumetanide—PTGS2—brain—acquired immunodeficiency syndrome	0.000196	0.00211	CbGeAlD
Bumetanide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000877	CcSEcCtD
Bumetanide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000873	CcSEcCtD
Bumetanide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000873	CcSEcCtD
Bumetanide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000861	CcSEcCtD
Bumetanide—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000189	0.00204	CbGeAlD
Bumetanide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000852	CcSEcCtD
Bumetanide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000844	CcSEcCtD
Bumetanide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000843	CcSEcCtD
Bumetanide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000836	CcSEcCtD
Bumetanide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000835	CcSEcCtD
Bumetanide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000833	CcSEcCtD
Bumetanide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000831	CcSEcCtD
Bumetanide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000811	CcSEcCtD
Bumetanide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000805	CcSEcCtD
Bumetanide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000805	CcSEcCtD
Bumetanide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000804	CcSEcCtD
Bumetanide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000799	CcSEcCtD
Bumetanide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000788	CcSEcCtD
Bumetanide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000774	CcSEcCtD
Bumetanide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000768	CcSEcCtD
Bumetanide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000767	CcSEcCtD
Bumetanide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000763	CcSEcCtD
Bumetanide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000758	CcSEcCtD
Bumetanide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000723	CcSEcCtD
